Social Media Posting(permalink)
Breaking News: The FDA is planning to warn that the Johnson & Johnson coronavirus vaccine can increase the risk of a rare nerve condition known as Guillain-Barré syndrome.
Review:
GBS is a (very rare) risk factor among already existing influenza vaccines: The consensus among medical experts, even neurologists who study and treat GBS, is that the benefits of the COVID-19 vaccine still far outweigh risks of GBS:
Review:
The FDA released a document with proof of a chance of Guillain-Barr? syndrome in the J&J vaccine.
Factors
veracity
MISINFORMED_OR_POTENTIALLY_MISLEADING, NOT_MISLEADING
conspiracyTheory
antivax conspiracy theory
Political Leaning
right political leaning
Emotion
fear
Sentiment
negative sentiment
Date published
2021-07-12
Entities
Guillain–Barré syndromeNerveJohnson & JohnsonFood and Drug AdministrationVaccineCoronavirusGold Bauhinia StarNeurologyInfluenza vaccineInfluenzaSevere acute respiratory syndrome coronavirus 2Women's National League (Ireland)